Literature DB >> 22102309

Induction of cyclin D1 by arsenite and UVB-irradiation in human keratinocytes.

Suqing Liu1, Julian Gonzalez, Bor-Jang Hwang, Mark L Steinberg.   

Abstract

Arsenic is an environmental pollutant with carcinogenic properties that is found in many regions of the world but that poses a health risk primarily in economically disadvantaged areas. In these areas, arsenic ingestion affects various tissues, especially skin in which it acts as a comutagen with the ultraviolet component of solar radiation. Both epidemiological and experimental evidence indicates that arsenic and ultraviolet radiation act on signaling pathways that effect the expression of cyclin D1. We have previously employed an in vitro model system of human epidermal keratinocytes to study the effects of submicromolar concentrations of sodium arsenite on cyclin D1 expression. Here, we employed this system to demonstrate concordant cyclin D1-related induction profiles of ultraviolet B radiation and arsenite using cDNA microarray analysis. We also show that both of these agents act epigenetically to bring about demethylation of the cyclin D1 promoter.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102309      PMCID: PMC4102378          DOI: 10.1353/hpu.2011.0158

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  44 in total

1.  Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice.

Authors:  Vijayalakshmi Nandakumar; Mudit Vaid; Trygve O Tollefsbol; Santosh K Katiyar
Journal:  Carcinogenesis       Date:  2010-12-24       Impact factor: 4.944

2.  Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary.

Authors:  M Börzsönyi; A Bereczky; P Rudnai; M Csanady; A Horvath
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

3.  Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis.

Authors:  J H Li; T G Rossman
Journal:  Mol Toxicol       Date:  1989

4.  In vivo genotoxicity evaluation of dimethylarsinic acid in MutaMouse.

Authors:  Yasuhiro Noda; Takayoshi Suzuki; Arihiro Kohara; Akira Hasegawa; Toshihisa Yotsuyanagi; Makoto Hayashi; Toshio Sofuni; Kenzo Yamanaka; Shoji Okada
Journal:  Mutat Res       Date:  2002-01-15       Impact factor: 2.433

5.  National human exposure assessment survey (NHEXAS): exploratory survey of exposure among population subgroups in EPA Region V.

Authors:  E D Pellizzari; R L Perritt; C A Clayton
Journal:  J Expo Anal Environ Epidemiol       Date:  1999 Jan-Feb

6.  Opposed arsenite-induced signaling pathways promote cell proliferation or apoptosis in cultured lung cells.

Authors:  Andy T Y Lau; Muyao Li; Ronglin Xie; Qing-Yu He; Jen-Fu Chiu
Journal:  Carcinogenesis       Date:  2003-09-26       Impact factor: 4.944

7.  Cancers related to exposure to arsenic at a copper smelter.

Authors:  P E Enterline; R Day; G M Marsh
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

8.  Arsenic induces human keratinocyte apoptosis by the FAS/FAS ligand pathway, which correlates with alterations in nuclear factor-kappa B and activator protein-1 activity.

Authors:  Wei-Ting Liao; Kee-Lung Chang; Chai-Li Yu; Gow-Shing Chen; Louis W Chang; Hsin-Su Yu
Journal:  J Invest Dermatol       Date:  2004-01       Impact factor: 8.551

9.  Case-control study of bladder cancer and arsenic in drinking water.

Authors:  M N Bates; A H Smith; K P Cantor
Journal:  Am J Epidemiol       Date:  1995-03-15       Impact factor: 4.897

10.  Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study.

Authors:  Fredric J Burns; Ahmed N Uddin; Feng Wu; Arthur Nádas; Toby G Rossman
Journal:  Environ Health Perspect       Date:  2004-04       Impact factor: 9.031

View more
  1 in total

Review 1.  Proteomic identification of a direct role for cyclin d1 in DNA damage repair.

Authors:  Siwanon Jirawatnotai; Yiduo Hu; David M Livingston; Piotr Sicinski
Journal:  Cancer Res       Date:  2012-08-22       Impact factor: 12.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.